Monday, February 29, 2016

'IVF chip' helps capture images of sperm fusing with egg

Every mammal on this planet starts in the same way: a sperm encounters an egg and fuses with it. This process is familiar to every eighth grade biology student, and pictures of the event can be found in every biology text book. However, despite this ubiquity, the detailed mechanics of the process itself is still somewhat of a mystery

Now, new techniques - featuring an "IVF chip" - presented recently at the Biophysical Society's 60th annual meeting in Los Angeles, CA, promise to reveal new insights into how a single sperm cell fuses with an egg cell.

The researchers hope the new techniques will help us better understand the causes of infertility and improve treatments.

At the meeting, Benjamin Ravaux, a physics graduate student at the Ecole Normale Supérieure de Paris in France, described how, using the "completely new approach," he and his colleagues captured high-resolution images of the events that unfold at the membrane of the egg cell during mammalian fertilization.

Ravaux says the "IVF chip" is a "unique tool to observe the cascade of molecular and membrane events occurring during the fertilization process," under conditions that mimic what happens in nature.

The idea and design of the device are the product of expertise in biophysics and fertilization and assisted reproduction technologies (ART) - including in vitro fertilization (IVF).

At the heart of the new approach is an "IVF chip" - a microfluidic device made from an electronic chip comprising several layers of silicon polymer sealed on a glass slide.

The design of the chip allows a sperm cell to be held in the bottom layer with an egg cell held above it, inside an "egg cup." At the bottom of the egg cup is a tiny opening, with a width of about 30 microns (roughly half the width of human hair).

Images of fertilization 'as it occurs'

When inserted in the lower layer of the chip, a sperm cell swims through the opening and fuses with the egg held in the egg cup.

The chip is compatible with confocal microscopy and other imaging systems, allowing the researchers to capture high-resolution images and movies of the fertilization process as it occurs.

The images show what happens to the sperm cell when it encounters the membrane of the egg cell. They show the two cells merging their membranes over time and the sperm cell gradually sinking into the egg cell.

The scientists also saw how the DNA in the sperm was assimilated into the egg's cytoplasm - the fluid surrounding the nucleus of the egg cell.

Ravaux explains that the new technique offers scientists the chance to investigate an area of reproductive biology that has remained largely unexplored due to lack of tools.

The IVF chip is different to what has been tried before because it allows scientists to observe what happens when just one sperm cell fuses with an egg. Other attempts to do this have had to settle with observing multiple sperm cells coming into contact with the membrane of the egg cell.

Ravaux says the technique could be combined with other approaches - such as fluorescent antibodies or genetically modified animals - to offer new insights into the membrane events of the sperm-meets-egg process. He concludes:
"An enhanced understanding of the molecular and physical mechanisms responsible for fertilization could ultimately lead to better methods to diagnose the causes of infertility, and improved personalized medicine treatments."


From a study published recently, Medical News Today learned how scientists in China have created functioning sperm from stem cells, raising hope that the approach may one day be used to treat male infertility.

Easy to Use Navik 3D Cardiac Mapping System Cleared in U.S.



APN Health, a firm based in Wisconsin, got hold of an FDA clearance to introduce its Navik 3D cardiac mapping system in the U.S. The system provides live tracking of catheters in 3D gathered from fluoroscopic 2D images, and combines that with the electrical cardiac signals to create volumetric maps of the heart.

The system uses existing fluoroscopes and ECG that are available in cath labs already, and so is the only cardiac mapping system on the market that does not rely on specialty equipment to interface with the patient.

The Navik 3D comes with its own display interface plus an iPad that can be carried around the cath lab that also displays the same available imagery including anatomical maps, cardiac electrical activation maps, and cardiac voltage maps.



http://www.medgadget.com

New Flexible Electronic Films for Body-Worn Medical Devices



At the École polytechnique fédérale de Lausanne, Switzerland researchers have created a new method for making stretchable electronics that may end up being integrated into wearables and medical devices. The prototype films can stretch up to four times their original shape and relax back without suffering any degradation in its electrical properties.

The researchers’ main achievement was achieving in making very narrow wires out of liquid metal (gold/gallium alloy) that bend along with the rest of the film but do not break down into individual pieces.. They’re only a few nanometers in width, and so can be used to connect multiple components within a single larger flexible device.

Here’s more about the new stretchable electronic films:



http://www.medgadget.com

Sunday, February 28, 2016

Medtronic’s CRT-Ds Now Approved for 3 Tesla Scanning in Europe

Medtronic won European CE Mark approval for a number of its cardiac resynchronization therapy defibrillators (CRT-Ds) to be safe for use under MRI imaging of up to 3 Tesla. The approved devices include the Claria MRI Quad CRT-D SureScan, Amplia MRI Quad CRT-D SureScan, and Compia MRI Quad CRT-D SureScan pacers. Additionally, all previously approved MRI-conditional cardiac implants now have a green light to be used in 3T magnetic resonance scanners in Europe.

All three devices use the firm’s Attain Perfoma MRI SureScan Quadripolar leads that come in three shapes to fit different patients, include steroid on the electrodes, and have short bipolar spacing that helps ameliorate phrenic nerve stimulation

Source: http://newsroom.medtronic.com

FDA Approves New ScandiDos System That Measures XRT Dose



When radiation treatment is delivered by a medical accelerator, the amount of exposure that is actually absorbed by the patient has been estimated based on dosage administered and other parameters. The Delta4 Discover, a product from ScandiDos, a Swedish firm, has received FDA clearance to be used to accurately measure the amount of radiation that moves past the patient and calculate the amount that’s actually absorbed.

The system allows for immediate verification of dosage delivered in a fairly non-intrusive way, letting techs go about the procedures pretty much as they normally would while knowing that the required therapy is being absorbed.

The detector simply sits on the receiving end of the radiation beam, past the patient, and counts the number of particles that strike it.

Here’s a promo video for the Delta4 Discover:


Source: http://www.medgadget.com

Automatic Suturing by Robotic Surgical System



At Case Western Reserve University engineers are working on integrating autonomous suturing abilities into the da Vinci robotically-assisted surgical system from Intuitive Surgical. The team managed to purchase a used da Vinci on eBay and are now developing autonomous algorithms to control the device while doing routine suturing. Here’s a couple of the team members presenting their project:


Source: http://www.medgadget.com

Top 5 Medical Technology Innovations



Against the backdrop of health care reform and a controversial medical device tax, medical technology companies are focusing more than ever on products that deliver cheaper, faster, more efficient patient care. They are also making inroads with U.S. Food & Drug Administration regulators to re-engineer the complex review and approval process for new medical devices.

Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care. To change that perception, the FDA last year announced a new Medical Device Innovation Consortium (MDIC) charged with simplifying the process of designing and testing new technologies. With input from industry, government, and other nonprofit organizations, public-private MDIC will prioritize the regulatory science needs of the medical device community and fund projects to streamline the process.

"By sharing and leveraging resources, MDIC may help industry to be better equipped to bring safe and effective medical devices to market more quickly and at a lower cost," says Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health.

As the regulators, politicians, and corporate executives hash out these details, industry engineers and scientists continue to push through new ideas for improving and managing human health. Every year, industry observers like the Cleveland Clinic and the medical device trade press single out their favorite technology trends. These thought leaders agree that today's best technologies strike a balance between reducing the overall cost of medical care and increasing safety and survival rates—and isn't that what health care reform is all about?

Here are five emerging technologies to watch in the year ahead.

1. Cutting Back on Melanoma Biopsies

With the most deadly form of skin cancer, melanoma, a huge number of dangerous-looking moles are actually harmless, but has always been impossible to know for sure without an invasive surgical biopsy. Today dermatologists have new help in making the right call — a handheld tool approved by the FDA for multispectral analysis of tissue morphology. The MelaFind optical scanner is not for definitive diagnosis but rather to provide additional information a doctor can use in determining whether or not to order a biopsy. The goal is to reduce the number of patients left with unnecessary biopsy scars, with the added benefit of eliminating the cost of unnecessary procedures. The MelaFind technology (MELA Sciences, Irvington, NY) uses missile navigation technologies originally paid for the Department of Defense to optically scan the surface of a suspicious lesion at 10 electromagnetic wavelengths. The collected signals are processed using heavy-duty algorithms and matched against a registry of 10,000 digital images of melanoma and skin disease.

2. Electronic Aspirin

For people who suffer from migraines, cluster headaches, and other causes of chronic, excruciating head or facial pain, the "take two aspirins and call me in the morning" method is useless. Doctors have long associated the most severe, chronic forms of headache with the sphenopalatine ganglion (SPG), a facial nerve bundle, but haven't yet found a treatment that works on the SPG long-term. A technology under clinical investigation at Autonomic Technologies, Inc., (Redwood City, CA) is a patient-powered tool for blocking SPG signals at the first sign of a headache. The system involves the permanent implant of a small nerve stimulating device in the upper gum on the side of the head normally affected by headache. The lead tip of the implant connects with the SPG bundle, and when a patient senses the onset of a headache, he or she places a handheld remote controller on the cheek nearest the implant. The resulting signals stimulate the SPG nerves and block the pain-causing neurotransmitters.

3. Needle-Free Diabetes Care

Diabetes self-care is a pain—literally. It brings the constant need to draw blood for glucose testing, the need for daily insulin shots and the heightened risk of infection from all that poking. Continuous glucose monitors and insulin pumps are today's best options for automating most of the complicated daily process of blood sugar management – but they don't completely remove the need for skin pricks and shots. But there's new skin in this game. Echo Therapeutics (Philadelphia, PA) is developing technologies that would replace the poke with a patch. The company is working on a transdermal biosensor that reads blood analytes through the skin without drawing blood. The technology involves a handheld electric-toothbrush-like device that removes just enough top-layer skin cells to put the patient's blood chemistry within signal range of a patch-borne biosensor. The sensor collects one reading per minute and sends the data wirelessly to a remote monitor, triggering audible alarms when levels go out of the patient's optimal range and tracking glucose levels over time.

4. Robotic Check-Ups

A pillar of health reform is improving access to the best health care for more people. Technology is a cost-effective and increasingly potent means to connect clinics in the vast and medically underserved rural regions of the United States with big city medical centers and their specialists. Telemedicine is well established as a tool for triage and assessment in emergencies, but new medical robots go one step further—they can now patrol hospital hallways on more routine rounds, checking on patients in different rooms and managing their individual charts and vital signs without direct human intervention. The RP-VITA Remote Presence Robot produced jointly by iRobot Corp. and InTouch Health is the first such autonomous navigation remote-presence robot to receive FDA clearance for hospital use. The device is a mobile cart with a two-way video screen and medical monitoring equipment, programmed to maneuver through the busy halls of a hospital.

5. A Valve Job with Heart

The Sapien transcatheter aortic valve is a life-saving alternative to open-heart surgery for patients who need new a new valve but can't endure the rigors of the operation. Manufactured by Edwards Life Sciences (Irvine, CA), the Sapien has been available in Europe for some time but is only now finding its first use in U.S. heart centers—where it is limited only to the frailest patients thus far. The Sapien valve is guided through the femoral artery by catheter from a small incision near the grown or rib cage. The valve material is made of bovine tissue attached to a stainless-steel stent, which is expanded by inflating a small balloon when correctly placed in the valve space. A simpler procedure that promises dramatically shorter hospitalizations is bound to have a positive effect on the cost of care.

Source: https://www.asme.org